STOCKHOLM, March 30, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company sees increased demand for AnaConDa as a result of the Covid-19 pandemic and so far, has had no significant supply chain disruptions. Sedana Medical forecasts a sales...
from PR Newswire: https://ift.tt/2ymraMB
No comments:
Post a Comment